The dark side of vaping: hidden health risks in South Africa's growing trend
South Africa's 2025 budget brings significant changes to sin tax, with new regulations affecting both traditional cigarettes ...
News Medical25d
Study links genetics to success of smoking cessation with varenicline
The effectiveness of a common drug to quit smoking could be down to people's genes, according to a study from the University of Leicester (United Kingdom). Varenicline is widely recognized as the ...
technologynetworks25d
Our Genetics May Explain Why Some People Find It Easier To Stop Smoking
The branded version of varenicline, Champix, has been unavailable since 2021 due to a manufacturing impurity. However, at the end of 2024, it was announced that a generic version of varenicline has ...
pharmaphorum4d
NHS England relaunches anti-smoking pill programme
A new generic version of varenicline – originally sold in the UK as Champix by Pfizer – has now been approved for use by the health service and could help "tens of thousands" of smokers quit ...
Hosted on MSN24d
Study sheds light on how people's DNA affects their response to smoking cessation drug
The branded version of varenicline, Champix, has been unavailable since 2021 due to a manufacturing impurity. However, at the end of 2024, it was announced that a generic version of varenicline ...
BMJ11d
Study protocol for a randomised controlled trial of Allen Carr’s Easyway programme versus Lambeth and Southwark NHS for smoking cessation
Introduction Smoking is a major cause of ill health and is associated with several diseases including cancer, coronary heart disease and stroke. Many psychological and pharmacological smoking ...